The Australian government said in November that the country remains on track to meet its 2035 goal, with national incidence falling to 6.3 cases per 100,000 women in 2021, down from 6.6 in 2020, and five-year survival improving to 76.8% in 2017-2021. Assistant Minister for Health Rebecca White said Australia is “leading the world in cervical cancer elimination,” while warning that the country must maintain momentum to make the goal a reality, according to the Australian Department of Health, Disability and Ageing.
Cervical cancer breakthrough is decades in the making
Public health experts caution that the milestone is not the result of one discovery, but of a layered prevention system. Australia launched its National Cervical Screening Program in 1991, introduced a national HPV vaccination program for girls in 2007, expanded vaccination to boys in 2013 and shifted from Pap smears to HPV-based screening in 2017. Universal self-collection became available in 2022, giving more people the option to take their own sample in a health care setting.
University of Sydney researchers framed the latest progress as the result of long-term policy, science and community partnerships. Prof. Karen Canfell, who leads the university’s Cancer Elimination Collaboration, said “elimination isn’t one breakthrough,” but a sustained effort involving vaccination, improved screening technologies, treatment access and community empowerment, according to the university’s May 2026 feature on how Australia is eliminating cervical cancer.
The World Health Organization defines elimination as fewer than four new cases per 100,000 women annually. Its global strategy rests on the 90-70-90 targets: vaccinating 90% of girls against HPV by age 15, screening 70% of women with a high-performance test by age 35 and again by 45, and treating 90% of women with precancer or invasive disease. Australia’s approach aligns with that framework while setting more ambitious national measures, including vaccination targets for boys as well as girls.
Older cervical cancer milestones show a clear trajectory
The latest news follows years of earlier warnings and projections that Australia was approaching a historic threshold. A 2019 Lancet Public Health modelling study projected that, if high vaccination and screening coverage were maintained, Australia could reach the elimination threshold within the next two decades. A later Cancer Council NSW research summary reinforced that the combined vaccination-and-screening model could make Australia the first country to eliminate the disease as a public health problem. In 2020, the Australian Centre for the Prevention of Cervical Cancer also said the country remained well positioned after the WHO launched its global elimination strategy, noting in an older ACPCC update that sustained participation would be essential.
That continuity matters because the new milestone comes with a warning. The 2025 progress report found HPV vaccine coverage by age 15 declined to 81.1% for females and 77.9% for males in 2024, down from earlier peaks. Screening participation has also slipped, with more than one in four eligible women overdue for screening by the end of 2024.
Why cervical cancer elimination still depends on equity
Australia’s national averages mask persistent gaps. The report found cervical cancer incidence among Aboriginal and Torres Strait Islander women was 11.7 per 100,000 in 2017-2021, compared with 5.8 per 100,000 among non-Indigenous women. Rates were also higher in remote and very remote areas, underscoring that elimination will not be achieved evenly unless screening, vaccination and follow-up treatment reach communities facing the largest barriers.
The national strategy aims to close those gaps by extending vaccination, screening and treatment goals beyond WHO’s baseline. The National Strategy for the Elimination of Cervical Cancer in Australia sets targets of 90% HPV vaccination for all eligible people, 70% five-yearly screening participation among eligible people ages 25 to 74, 95% treatment for cervical precancer and cancer, and fewer than four cases per 100,000 women by 2035.
The stakes extend beyond Australia. Cervical cancer remains the fourth most common cancer among women globally, and the vast majority of deaths occur in countries with limited access to vaccination, screening and treatment. If Australia reaches its 2035 goal, it would offer proof that the WHO cervical cancer elimination initiative can move from aspiration to measurable national success.
For now, Australia’s breakthrough is both a celebration and a test. The absence of cases among women under 25 shows the power of vaccination and screening among younger cohorts. The next challenge is ensuring that the same protection reaches older, remote, Indigenous, multicultural, LGBTQIA+, disabled and under-screened communities before the 2035 deadline arrives.
